These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17330181)

  • 1. Ischaemic stroke in patients with patent foramen ovale.
    Piechowski-Jóźwiak B; Kwieciński H
    Neurol Neurochir Pol; 2007; 41(1):55-63. PubMed ID: 17330181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke.
    Ghosh S; Ghosh AK; Ghosh SK
    Postgrad Med J; 2007 Mar; 83(977):173-7. PubMed ID: 17344571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale in cryptogenic stroke: current understanding and management options.
    Wu LA; Malouf JF; Dearani JA; Hagler DJ; Reeder GS; Petty GW; Khandheria BK
    Arch Intern Med; 2004 May; 164(9):950-6. PubMed ID: 15136302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryptogenic stroke and patent foramen ovale].
    Windecker S; Nedeltchev K; Wahl A; Meier B
    Ther Umsch; 2003 Sep; 60(9):553-61. PubMed ID: 14579624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Windecker S; Wahl A; Nedeltchev K; Arnold M; Schwerzmann M; Seiler C; Mattle HP; Meier B
    J Am Coll Cardiol; 2004 Aug; 44(4):750-8. PubMed ID: 15312853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with stroke and a patent foramen ovale.
    Rodriguez CJ; Homma S
    Curr Cardiol Rep; 2004 Mar; 6(2):143-6. PubMed ID: 14759360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with stroke and a patent foramen ovale.
    Rodriguez CJ; Homma S
    Curr Neurol Neurosci Rep; 2004 Jan; 4(1):19-22. PubMed ID: 14683623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale and stroke: what we do and don't know.
    Kim D; Saver JL
    Rev Neurol Dis; 2005; 2(1):1-7. PubMed ID: 16400296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interest of surgical closure of patent foramen ovale after stroke: a preliminary open study of 8 cases.
    Giroud M; Tatou E; Steinmetz E; Lemesle M; Cottin Y; Wolf JE; Moreau T; David M
    Neurol Res; 1998 Jun; 20(4):297-301. PubMed ID: 9618691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
    Mas JL; Arquizan C; Lamy C; Zuber M; Cabanes L; Derumeaux G; Coste J;
    N Engl J Med; 2001 Dec; 345(24):1740-6. PubMed ID: 11742048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.
    Cujec B; Mainra R; Johnson DH
    Can J Cardiol; 1999 Jan; 15(1):57-64. PubMed ID: 10024860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale and cerebrovascular diseases.
    Desai AJ; Fuller CJ; Jesurum JT; Reisman M
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):446-55. PubMed ID: 16874357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke.
    Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):625-9. PubMed ID: 16548006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
    Schuchlenz HW; Weihs W; Berghold A; Lechner A; Schmidt R
    Int J Cardiol; 2005 May; 101(1):77-82. PubMed ID: 15860387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent foramen ovale and stroke: prognosis and treatment in young adults.
    Cramer SC
    J Thromb Thrombolysis; 2005 Oct; 20(2):85-91. PubMed ID: 16205857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
    Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of patients with patent foramen ovale and cryptogenic stroke: our experience and review of the literature.
    Bailey CE; Allaqaband S; Bajwa TK
    WMJ; 2004; 103(4):32-6. PubMed ID: 15481868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical closure of patent foramen ovale in patients with suspected paradoxical embolism: long-term results.
    Gasiavelis N; Grinnemo KH; Lindblom D; Dellgren G
    Scand Cardiovasc J; 2004 Dec; 38(6):375-9. PubMed ID: 15804806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
    Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
    J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.